Add like
Add dislike
Add to saved papers

The melanocytic differentiation pathway in congenital melanocytic nevi: theoretical considerations.

It is suggested that the melanocytic series is characterized by a differentiation pathway (MDP) that has four discrete stages during normal development and in postnatal tissue maintenance--nerve sheath precursor (nsp), dermal migratory, junctional migratory, and dendritic--and that congenital melanocytic nevi (CMN) derive from cells in the nsp stage of the MDP. This concept accounts satisfactorily for morphologic variations and clinicopathologic correlations in CMN. It also permits a unified explication of both similarities and differences between congenital and acquired melanocytic nevi (AMN), which are thought to arise by transformation of nsp cells in the MDP during postnatal tissue maintenance. This perspective suggests that answers to many basic questions about CMN may require meticulous study of the interrelations of CMN with peripheral nerve elements. Such research may be necessary to resolve current controversies about optimal criteria for distinguishing small CMN from AMN, thereby permitting an accurate assessment of the risk of malignant melanoma in association with small CMN.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app